AYA-NAV for Adolescent and Young Adult Cancer Survivors
This study, called AYA-NAV, is looking at ways to help adolescent and young adult (AYA) cancer survivors (ages 15-39) with financial and social needs related to their health. The study will test a program that combines digital tools and personal support to help survivors find resources for things like financial strain, food insecurity, housing, and job support. Researchers want to see if this program can reduce financial stress and improve overall health for AYAs and their caregivers. You may be able to join if you are an AYA who has had a cancer diagnosis or started treatment within the last 6 months, or are currently on your first treatment, and speak English or Spanish. The study aims to enroll 120 participants.
- Study design
- This interventional study plans to enroll 120 participants. It will evaluate the feasibility and acceptability of the AYA-NAV program.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Feasibility measures like recruitment, consent, and retention rates will be measured for up to 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Recruitment rate (feasibility)Up to 6 months
Percent eligible out of total screened
- Consent rate (feasibility)Up to 6 months
Percent consented out of eligible total
- Retention rates (feasibility)Up to 6 months
Percent of enrolled that completed the 6-month assessment
- Comprehensive Score of Financial Toxicity (COST) scorebaseline, 6-months
The COST is a patient-reported outcome measure that describes the financial distress experienced by cancer patients. It is a 11-item questionnaire with a score range of 0-44. Lower COST values indicate higher toxicity. Higher scores indicate lower financial toxicity.